PRME
Prime Medicine, Inc. Common Stock
NASDAQ: PRME · HEALTHCARE · BIOTECHNOLOGY
$3.53
-4.34% today
Updated 2026-04-29
Market cap
$666.47M
P/E ratio
—
P/S ratio
143.88x
EPS (TTM)
$-1.35
Dividend yield
—
52W range
$1 – $7
Volume
2.5M
Prime Medicine, Inc. Common Stock (PRME) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-5,800.00%
ROE
-146.80%
ROA
-40.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-2.53M | — | — | — |
| 2020 | $5.21M | $-3.41M | 42.80% | -17.89% | -65.45% |
| 2021 | $0.00 | $-165.37M | — | — | — |
| 2022 | $5.21M | $-121.82M | -230.60% | -2,236.93% | -2,338.21% |
| 2023 | $0.00 | $-198.13M | — | — | — |
| 2024 | $2.98M | $-195.88M | 100.00% | -6,787.36% | -6,566.61% |
| 2025 | $4.63M | $-201.14M | -58.05% | -4,498.06% | -4,342.44% |